1Nakayama K, Takebayashi Y, Nakayama S, et al. Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving ciplatin. Cancer Lett. 2003, 192:227-235.
2Skirnisd6ttir I, Seidal T, Gerdin E, et al. The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy. Int J Gynecol Cancer, 2002, 12: 265-276.
3Ozalp S, Yalcin OT, Minsin TH. Expression of p53 in epithelial ovarian cancer. Int J Gvnecol Obstet, 2000, 71(3): 277-278.
4Sagarra RAM, Andrade LALA, Martinez EZ, et al. p53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer. Int J Gynecol Cancer, 2002. 12:720-727.
5Sui L, Dang Y, Ohno M, et al. Inverse expression of cdk4 and p16 in eoithelial ovarian tumors. Gynecol Oncol, 2000, 79(2): 230-237.
6Kudoh K, Ichikawa Y, Yoshida S,et al. Inactivation of p l6/CDKN2 and pl5/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer. Int J Cancer, 2002, 9(4): 579-582.
7Newcomb EW, Sosnow M, Demopoulos RI, et al. Expression of the cell cycle inhibitor p27^kipl is a new prognostic marker associated with survival in epithelial ovarian tumors. Am J Pathol, !999, 154(1): 119-125.
8Masciullo V, Ferrandina G, Pucci B, et al. p27^kipl expression is associated with clinical outcome in advanced epithelial ovarian cancer:muhivariated analysis. Clin Cancer Res, 2000,6(12): 4816-4822.
9Schuyer M, van der Burg MEL, Henzen-Logmans Sc, et al. Reduced expression of BAX is associated with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2. Br J Cancer,2001, 85(9): 1359-1367.
10Baekelandt M, Holm R, Nesland JM, et al. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer. J Clin Oneol, 2000, 18(22): 3775-3781.
3Mirecka J,Marx D,Schauer A,et al.Immunohistochemical localization of CD44 variants 5 and 6 in human gastric mucosa and gastric cancer[J].Antricaneer Res,1995,15(4):1459-1465.
4Dall P,Heider K H,Sinn H P,et al.Comparison of immunohistochemistry and RT-PCR for detection of CD44-expression:a new prognostic factor in human breast cancer[J].Int J Cancer,1995,60(4):471-477.
5Uhl Steidl M,Miller Holzner E,Zeimet A G,et al.Prognostic of CD44splice Variant expression in ovarian cancer[J].Oncology,1995,52(5):400-406.
6Hale A J, Smith C A,Sutherland L C, et al. Apoptosis: molecular regulation of cell death[J].Eur J Biochem, 1996, 236:1-26.
7Sui L, Tokuda M, Ohno M, et al, The concurrent expression of p27(kipl) and Cylin D1 in epithelial ovarian tumors[J]. Gynecol Oncol,1999, 73(2):202-209.
8Lloyd R V,Erckson L A,Jin L,et al.p27kipl,a multifuctional Cyclin-Dependent kinase inhibitor with prognostic significance in human cancers[J].Am J Pathol,1999,154(2):313-323.
